Torbay Pharma

Torbay Pharma is a leading UK-based pharmaceutical manufacturer specializing in sterile injectable products. Formerly an NHS-owned entity known as Torbay Pharmaceuticals, the company was acquired by private equity firm NorthEdge Capital in 2023 to drive international growth and expand its contract development and manufacturing organization (CDMO) capabilities. The company offers a diverse portfolio of licensed and unlicensed medicines, including analgesics, electrolytes, and nutritional supplements. Operating from a state-of-the-art MHRA-licensed facility in Devon, Torbay Pharma provides end-to-end manufacturing services from formulation development to commercial-scale production. Its products are essential to secondary care providers both within the UK and across global markets.